110 related articles for article (PubMed ID: 1030269)
1. A Singapore study of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis (1).
Lee SK
Bull Int Union Tuberc; 1976; 51(1):109-13. PubMed ID: 1030269
[No Abstract] [Full Text] [Related]
2. Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore. The results up to 30 months.
Am Rev Respir Dis; 1977 Nov; 116(5):807-20. PubMed ID: 411405
[No Abstract] [Full Text] [Related]
3. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.
Lancet; 1975 Dec; 2(7945):1105-9. PubMed ID: 53598
[TBL] [Abstract][Full Text] [Related]
4. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
Nitti V
Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
[No Abstract] [Full Text] [Related]
5. [The short course therapies by Ryoken's method. 9 month and 12 month regimens including rifampicin (RFP) plus isoniazid (INH) in bacteriologically proved pulmonary tuberculosis].
Gomi J; Aoyagi T; Fukuhara Y; Yamaguchi T; Matsumiya T
Kekkaku; 1985 Aug; 60(8):435-45. PubMed ID: 3906218
[No Abstract] [Full Text] [Related]
6. Two-three years follow up study of pulmonary tuberculosis treated 6 months with rifampicin-containing regimens.
Pecak W; Leowski J; Nachman-Bijas J; Mroz-Czajka D; Trzcinski K; Wlazlo Z
Bull Int Union Tuberc; 1976; 51(1):159-62. PubMed ID: 1030277
[No Abstract] [Full Text] [Related]
7. Intermittent treatment using isoniazid and rifampicin once a week: final results of a controlled trial.
Eule H; Iwainsky H; Kaernbach E; Kaluza P; Saerens E; Werner E
Bull Int Union Tuberc; 1976; 51(1):115-9. PubMed ID: 1030270
[No Abstract] [Full Text] [Related]
8. Simplified short-course treatment of pulmonary tuberculosis: experience with a regimen of ethambutol, rifampicin and isoniazid for 2 months followed by isoniazid or rifampicin for 4 months.
Gonzalez Montaner LJ; Leston JM; Cetrangolo A; Szemzo J; Calvete C; Dambrosi A; Mosca C
Bull Int Union Tuberc; 1976; 51(1):87-9. PubMed ID: 1030316
[No Abstract] [Full Text] [Related]
9. Serum concentration of isoniazid following administration of the drug alone and in combination with rifampicin in patients of pulmonary tuberculosis.
Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP
Indian J Physiol Pharmacol; 1986; 30(1):115-7. PubMed ID: 3818028
[No Abstract] [Full Text] [Related]
10. [Comparative study (in a controlled therapeutic trial) of 3 intermittent regimens, after an initial period of daily administration, in the repeated treatment of pulmonary tuberculosis (results)].
Fraga H; Gomes O; Paz de Almeida A; Gerhardt G; Santiago AC
Bull Int Union Tuberc; 1973 Jun; 48(0):125-38. PubMed ID: 4602467
[No Abstract] [Full Text] [Related]
11. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
[No Abstract] [Full Text] [Related]
13. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
Teo SK
Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
[TBL] [Abstract][Full Text] [Related]
14. [Long term results of short course chemotherapy in pulmonary tuberculosis--(1st study):twelve- and eighteen-month chemotherapy with rifampicin-isoniazid and ethambutol].
Baba H; Schinkai A; Izuchi R; Azuma Y
Kekkaku; 1986 Jul; 61(7):371-7. PubMed ID: 3761792
[No Abstract] [Full Text] [Related]
15. [Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin].
González Montaner LJ; Palma Beltrán O; Abbate E; Dambrosi A; Mosca C
Bull Int Union Tuberc; 1983 Jun; 58(2):108-10. PubMed ID: 6360262
[No Abstract] [Full Text] [Related]
16. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
Kawakami K
Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849
[TBL] [Abstract][Full Text] [Related]
17. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
[TBL] [Abstract][Full Text] [Related]
18. [Late results of treatment with rifampicin combined with SM and INH in newly detected cases of pulmonary tuberculosis].
Szymański A
Pneumonol Pol; 1976 Mar; 44(3):227-35. PubMed ID: 1257096
[No Abstract] [Full Text] [Related]
19. [Comparative study of the treatment of pulmonary tuberculosis by a combination of rifampicin and isoniazid administered daily and twice weekly for a year].
Decroix G; Kreis B; Sors C; Birenbaum J; Le Lirzin M; Canetti G
Rev Tuberc Pneumol (Paris); 1971; 35(1):39-54. PubMed ID: 5559724
[No Abstract] [Full Text] [Related]
20. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
Dubra F
Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
[No Abstract] [Full Text] [Related]
[Next] [New Search]
